为2型糖尿病降糖干预实效试验选择核心结局集(SCORE-IT):核心结局集开发研究方案
SCORE-IT研究计划为2型糖尿病降糖干预的所有试验开发一套核心结局集(COS)。研究分三阶段:从注册临床试验、在线患者资源、定性文献和里程碑研究等多来源识别结局清单;由多利益相关群体参与的两轮在线国际德尔菲调查对结局评分;召开面对面共识会议汇总讨论德尔菲结果。该COS旨在提高结局一致性,使研究结果可比较与合并,加速有效治疗可用。
要点
- SCORE-IT旨在为2型糖尿病降糖干预试验建立国际适用的核心结局集。
- 结局清单来源于注册临床试验、患者资源、定性文献和里程碑研究。
- 通过两轮在线国际德尔菲调查和多利益相关方共识会议确定核心结局。
核心结论
- SCORE-IT研究旨在开发一套用于2型糖尿病降糖干预所有试验的核心结局集(COS)。
- 使用COS有望提高结局一致性,使研究结果可比较与合并,并加速有效治疗的可及。
研究设计与样本
- 研究方案包括三个阶段:多来源识别结局清单、两轮在线国际德尔菲调查评分、面对面共识会议。
- 结局清单来源包括注册临床试验、在线患者资源、定性文献和研究指导委员会确定的里程碑研究。
- 德尔菲调查由多个利益相关群体参与评分,共识会议有所有利益相关群体代表参加。
- 该COS研究已在COMET数据库注册(注册号956),注册时间为2017年1月。
临床怎么用
- 未来2型糖尿病降糖干预试验可采用该COS统一报告核心结局,便于跨研究比较与合并。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trials of glucose-lowering interventions. This inconsistency affects the ability to compare findings and may mean that the results have little importance to health care professionals and the patients for whom they care. The SCORE-IT study aims to develop a core outcome set (COS) for use in all trials of glucose-lowering interventions for people with type 2 diabetes. METHODS/DESIGN: This study will involve three key stages in the development of a COS: (1) A list of outcomes will be identified from multiple sources, specifically registered clinical trials, online patient resources, the qualitative literature and landmark studies identified by a Study Steering Committee. (2) The list of outcomes will be scored by multiple stakeholder groups in a two-round online international Delphi survey. (3) The results of the online Delphi will be summarised and discussed at a face-to-face consensus meeting with representation from all stakeholder groups. DISCUSSION: The SCORE-IT study aims to develop an internationally relevant set of core outcomes for use in future trials of glucose-lowering interventions for type 2 diabetes. The use of a COS will improve the consistency of outcomes, allowing results of studies to be compared and combined and for new effective treatments to made available more quickly. TRIAL REGISTRATION: The COS study, of which this is a part, is registered in the Core Outcome Measures in Effectiveness Trials (COMET) database, http://www.comet-initiative.org/studies/details/956 . Registered January 2017.
引用
- Harman NL, Wilding J, Curry D, et al. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set. Trials. 2018. PMID: 30086771. doi:10.1186/s13063-018-2805-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。